Industry Insights: Drug Shortages and Alternative Sourcing Opportunities

Drug shortages have decreased, but supply chain complexity requires ongoing innovation and resilience to maintain drug availability.

By McKesson Health Systems Editorial Team

Date

March 31, 2025

Read Time

3 minutes

Drug shortages have been a persistent issue in healthcare, posing significant challenges for health systems and patients alike. These shortages can disrupt the availability of critical medications, leading to delays in treatment and increased operational burdens for healthcare providers. By collaborating across the continuum of care to strengthen our supply chain, the industry is continuously innovating and finding ways to mitigate drug shortages.

In the article "Drug Shortages and Alternative Sourcing Opportunities," published in Pharmacy Times, Stephen Stalker, VP of Drug Shortages at McKesson, discusses the industry's efforts to address these challenges. Read the full article here.

Subscribe Now

To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.

Brittany Ulrich, PharmD, CSP, BCBBS, examines how limited distribution drugs and payer requirements push specialty prescriptions outside the organization, eroding visibility into patient outcomes, and how Biologics by McKesson helps health systems expect more when it comes to maintaining care continuity.

Aerial view of a large warehouse complex with loading docks, trucks and intersecting roads.

Case Study: How McKesson’s Winter-Storm Playbook Kept Specialty Drugs Moving

Expect more for the business of pharmacy with a pressure-tested, multi-layered business continuity strategy.

Researcher in a laboratory looks through shelving lined with containers and supplies.

What You Should Know About the CMS Proposed 340B Payment Change

Dr. Andrew Wilson, B.S., Pharm.D., FASHP, reflects on the proposed CY 2027 OPPS rule for several outpatient drugs purchased through the 340B program, and the next phase of specialty drug margin management for the business of pharmacy.

Open laptop beside a stack of tabbed documents in a binder on a desk, with a softly blurred office background.

Top Prescribed Perspectives Reads for August

The top three Prescribed Perspectives articles most read by health systems in August.

Business professionals greet with a handshake in a modern office while colleagues stand nearby during a networking conversation.

Upcoming Event: inSPire 2026

Connect with McKesson at inSPire to help shape the future of specialty pharmacy

Healthcare professional and colleague review information on a tablet in a clinical setting.

Where Does Your Health System Fall on the Specialty and Infusion Growth Journey?

With our assessment, benchmark your progress across the specialty and infusion journey to achieve more for the business of pharmacy.

Industry Insights: Drug Shortages and Alternative Sourcing Opportunities

Related Stories

Related Tags